Paper19948837
The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.
Hyams C and 4 others. Infect Immun, 2010. Cited by 348 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Papers, record 19948837. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19948837
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Capsules | Major topic |
| Complement Activation | Major topic |
| Neutrophils | Major topic |
| Phagocytosis | Major topic |
| Streptococcus pneumoniae | Major topic |
| Cell Separation | |
| Complement System Proteins | |
| Enzyme-Linked Immunosorbent Assay | |
| Flow Cytometry | |
| Humans | |
| Virulence |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0600410 | Medical Research Council | United Kingdom | PubMed | |
| G0700829 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,086,214 | Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence. | Mol Microbiol | 2008 | https://conductscience.org/library/papers/18086214 | PubMed |
| 2 | 15,794,969 | WHO estimates of the causes of death in children. | Lancet | 2005 | https://conductscience.org/library/papers/15794969 | PubMed |
| 3 | 3,950,449 | Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. | J Infect Dis | 1986 | https://conductscience.org/library/papers/3950449 | PubMed |
| 4 | 2,554,337 | Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2554337 | PubMed |
| 5 | 18,541,650 | Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. | Infect Immun | 2008 | https://conductscience.org/library/papers/18541650 | PubMed |
| 6 | 12,496,169 | Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. | Infect Immun | 2003 | https://conductscience.org/library/papers/12496169 | PubMed |
| 7 | 17,983,446 | Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. | Clin Exp Immunol | 2008 | https://conductscience.org/library/papers/17983446 | PubMed |
| 8 | 19,521,509 | Pneumococcal capsular polysaccharide structure predicts serotype prevalence. | PLoS Pathog | 2009 | https://conductscience.org/library/papers/19521509 | PubMed |
| 9 | 2,634 | The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. | J Immunol | 1976 | https://conductscience.org/library/papers/2634 | PubMed |
| 10 | 16,540,281 | Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae. | Microb Pathog | 2006 | https://conductscience.org/library/papers/16540281 | PubMed |
| 11 | 15,574,492 | Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15574492 | PubMed |
| 12 | 15,263,032 | The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. | J Exp Med | 2004 | https://conductscience.org/library/papers/15263032 | PubMed |
| 13 | 16,040,978 | Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. | Infect Immun | 2005 | https://conductscience.org/library/papers/16040978 | PubMed |
| 14 | 8,890,251 | Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. | Infect Immun | 1996 | https://conductscience.org/library/papers/8890251 | PubMed |
| 15 | 17,845,072 | Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. | PLoS Pathog | 2007 | https://conductscience.org/library/papers/17845072 | PubMed |
| 16 | 15,122,528 | The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. | J Infect Dis | 2004 | https://conductscience.org/library/papers/15122528 | PubMed |
| 17 | 16,034,123 | Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. | J Immunol | 2005 | https://conductscience.org/library/papers/16034123 | PubMed |
| 19 | 1,709,919 | Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens. | Infect Immun | 1991 | https://conductscience.org/library/papers/1709919 | PubMed |
| 20 | 16,707,578 | Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16707578 | PubMed |
| 21 | 7,353,656 | Absence of cytochrome b reduction in stimulated neutrophils from both female and male patients with chronic granulomatous disease. | FEBS Lett | 1980 | https://conductscience.org/library/papers/7353656 | PubMed |
Cited by278
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 348 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,783,958 | Antibacterial and Antibiofilm Activity of Aspergillus-Derived Gliotoxin Against Streptococcus pneumoniae and Staphylococcus aureus: Interaction with Conventional Antibiotics. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42783958 | PubMed |
| 42,725,773 | The role of the polysaccharide capsule as a novel virulence-associated trait of Stenotrophomonas maltophilia complex bacteria. | mBio | 2026 | https://conductscience.org/library/papers/42725773 | PubMed |
| 42,625,184 | Clinical and laboratory features of pediatric Mycoplasma pneumoniae Pneumonia with viral versus bacterial co-infection. | Ital J Pediatr | 2026 | https://conductscience.org/library/papers/42625184 | PubMed |
| 42,377,912 | Feeding the invaders: how metabolic imbalance shapes infection and biofilm development. | FEMS Microbiol Rev | 2026 | https://conductscience.org/library/papers/42377912 | PubMed |
| 42,359,010 | Investigation of the essential role of capsular polysaccharide in serotype 1 Streptococcus pneumoniae. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42359010 | PubMed |
| 42,322,679 | Half a century of pneumococcal vaccination in sickle cell disease: Are we winning the battle or losing immunity? | Vaccine | 2026 | https://conductscience.org/library/papers/42322679 | PubMed |
| 42,318,905 | The oral-respiratory interface: modulation of Streptococcus pneumoniae serotype adhesion by the periodontal pathogen Porphyromonas gingivalis W83. | Future Microbiol | 2026 | https://conductscience.org/library/papers/42318905 | PubMed |
| 42,183,770 | A synopsis of competence-regulated virulence in Streptococcus pneumoniae. | Virulence | 2026 | https://conductscience.org/library/papers/42183770 | PubMed |
| 42,117,705 | Clinical characteristics, risk factors, and pathogen spectrum of mixed infections in children with Mycoplasma pneumoniae pneumonia: a retrospective cohort study of 1,428 cases from a children's medical centre in East China. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42117705 | PubMed |
| 42,039,541 | An unrecognized host response to microbial exposure resets circadian timing. | bioRxiv | 2026 | https://conductscience.org/library/papers/42039541 | PubMed |
| 42,006,177 | Il vaccino coniugato antipneumococcico 21-valente per la prevenzione delle infezioni da Streptococcus pneumoniae in età adulta: una valutazione di Health Technology Assessment. | J Prev Med Hyg | 2026 | https://conductscience.org/library/papers/42006177 | PubMed |
| 41,977,167 | Capsule and PspA Cooperatively Confer Resistance of Streptococcus pneumoniae to the Human Defensin HNP-1. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977167 | PubMed |
| 41,893,745 | Future Pneumococcal Vaccines: Shifting from Capsular Polysaccharides to Protein-Based Immunogens. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893745 | PubMed |
| 41,860,230 | PneumoWiki: a pan-genome-based database for the pathogen Streptococcus pneumoniae. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41860230 | PubMed |
| 41,803,082 | Transcriptional regulation of the pneumococcal capsule can dictate serotype-specific infection. | Nat Commun | 2026 | https://conductscience.org/library/papers/41803082 | PubMed |
| 41,756,780 | Host-pathogen interaction in community-acquired pneumonia: a focus on the immune response. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41756780 | PubMed |
| 41,732,679 | Overcoming phagocytosis resistance of hypervirulent Klebsiella pneumoniae by directly targeting capsules. | Microb Cell | 2026 | https://conductscience.org/library/papers/41732679 | PubMed |
| 41,678,533 | Identification of multiple Acinetobacter baumannii protein antigens as targets for potential immunotherapies using a novel protein microarray screening approach. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41678533 | PubMed |
| 41,549,468 | Basal activation of ERK1/2 blunts the antimicrobial activity of neutrophils from old hosts against antibody-opsonized Streptococcus pneumoniae. | J Leukoc Biol | 2026 | https://conductscience.org/library/papers/41549468 | PubMed |
| 41,513,971 | Stevioside curbs Streptococcus pneumoniae infection via inhibiting capsule biosynthesis. | Commun Biol | 2026 | https://conductscience.org/library/papers/41513971 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19948837
GET https://conductscience.org/api/papers/v1/19948837/references?page=2